You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

VORTIOXETINE HYDROBROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Vortioxetine Hydrobromide, and what generic alternatives are available?

Vortioxetine Hydrobromide is a drug marketed by Zydus Pharms and is included in one NDA.

The generic ingredient in VORTIOXETINE HYDROBROMIDE is vortioxetine hydrobromide. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vortioxetine hydrobromide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VORTIOXETINE HYDROBROMIDE?
  • What are the global sales for VORTIOXETINE HYDROBROMIDE?
  • What is Average Wholesale Price for VORTIOXETINE HYDROBROMIDE?
Drug patent expirations by year for VORTIOXETINE HYDROBROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for VORTIOXETINE HYDROBROMIDE
Paragraph IV (Patent) Challenges for VORTIOXETINE HYDROBROMIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TRINTELLIX Tablets vortioxetine hydrobromide 5 mg, 10 mg, 15 mg and 20 mg 204447 15 2017-10-02

US Patents and Regulatory Information for VORTIOXETINE HYDROBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms VORTIOXETINE HYDROBROMIDE vortioxetine hydrobromide TABLET;ORAL 211146-001 Sep 17, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms VORTIOXETINE HYDROBROMIDE vortioxetine hydrobromide TABLET;ORAL 211146-002 Sep 17, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms VORTIOXETINE HYDROBROMIDE vortioxetine hydrobromide TABLET;ORAL 211146-003 Sep 17, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.